Can Stem-Cell implants restore movement in Parkinson's?

NCT ID NCT07733349

Not yet recruiting Disease control Sponsor: Shanghai UniXell Biotechnology Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether implanting dopamine-producing cells into the brain can improve motor function in people with Parkinson's disease. The cells, made from stem cells, are surgically placed into the putamen. The study focuses on safety and whether the treatment can reduce symptoms like stiffness and tremors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: implanted dopamine-producing cells made from stem cells
What this could lead to: If it works, this could point toward a cell-replacement therapy that restores dopamine production and improves motor symptoms in Parkinson's disease.
What could go wrong: This is an early-phase trial with only 12 participants, so safety and effectiveness are not yet established. The surgical implantation carries risks such as bleeding, infection, or immune rejection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON'S DISEASE

Contacts and locations

Locations

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, 200025, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.